RBM47 and cholangiocarcinoma: Correspondingly, we found the protein expression of P53 was elevated in the RBM47‐mutant cell lines (Figure S3E,F), which suggested that RBM47 mutations promoted CCA tumor cell proliferation by enhancing the P53/P21 pathway.